Global Automatic Cell Imaging System Market - 2022-2029

Market Overview

The global automatic cell imaging system market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 9.1% during the forecast period (2022-2029).

Automated image analysis employs software to isolate data from digital images. Algorithms identify specific shapes and patterns in the images and compile quantitative information that is then utilized in cell imaging studies of cellular structure and function in cells. It enables the visualization and quantitation of dynamic cellular processes in real-time.

Market Dynamics

The increasing research activities and related funding from various entities will boost the global automatic cell imaging system market growth during the forecast period.

The increased research initiatives and findings fuel its demand in the global market.

As life sciences and biomedicine studies advance, they become more sophisticated and require automated technology to maintain the data throughput necessary for scientific advancement. Microscopic imaging of biological processes is a fundamental data acquisition and analysis technique used in biomedical research. Therefore, the growing research initiatives and funding in biomedicine boost the global automatic cell imaging system market. For instance, the independent ISREC Foundation focused on supporting innovative cancer research in Lausanne and Western Switzerland, particularly translational oncology that is guaranteed to positively impact the future treatment of cancer patients. Moreover, in 2020 the estimated funding budget for research according to the NCI for various chronic diseases was $6,440.4 million, and the Professional Judgement Budget Proposal for the fiscal year 2024 is $9988 million. Similarly, in July 2021, the Cancer Research Institute (CRI), a U.S. nonprofit organization dedicated to saving more lives through the discovery and development of potent immunotherapies for all cancers, reported that it had awarded more than $28.5 million in research grants and fellowships during the 2021 fiscal year ending June 30, 2021. Thus, the increased research initiatives and findings for biomedicines are boosting the growth of the global automatic cell imaging system during the forecasted period.

The high cost of the automatic cell imaging system will hamper the global automatic cell imaging system market growth.

However, the high cost of the automatic cell imaging system is expected to hamper the global market growth. For instance, according to Avantor, the ImageXpress Pico Automated Cell Imaging System costs from $69,727.58 to $81,637.99 based on the specifications.

COVID-19 Impact Analysis

COVID-19 has positively impacted the global automatic cell imaging system market since post-COVID, and increased investments in biomedical research have been made. For instance, according to Research America, a non-profit medical and health research advocacy association, the United States (U.S.) medical and health research and development (R&D) investment reached $245.1 billion in 2020, an 11.1% increase from 2019. The 2020 estimates suggest changes in growth rates across the public-private sector R&D ecosystem, but it is likely these changes predominantly reflect the reaction to, and effect of, the COVID-19 pandemic.

Segment Analysis

Live cell and in vivo imaging are predicted to dominate the forecast period (2022-2029).

Live cell and in vivo imaging are estimated to hold most of the global automatic cell imaging system market throughout the forecast period (2022-2029) because of the new product introductions by various market payers. For instance, in Oct 2020, CytoSMART Technologies launched Multi Lux, a new automated live-cell imaging system developed for long-term experiments, comparison studies, and large laboratory teams. Similarly, in September 2021, PHC Corporation of North America and Screen Holdings Co., Ltd partnered to market the Screen Cell imager series of live cell imaging systems in North America. Additionally, in April 2022, CytoSMART technologies introduced the Omni FL, a new live-cell imaging analysis system containing red and green fluorescence channels, into its signature Omni product line for the first time. Furthermore, in June 2021, Leica Microsystems introduced its Leica Nano workflow, a brand new live-cell correlative light and electron microscopy (CLEM) workflow solution developed to improve experimental success rates, reproducibility and simplify light and electron microscopy (EM) integration. Thus, the increasing product introduction for live cell and in vivo imaging ensures its dominance over the global automatic cell imaging system market during the forecast period.

Geographical Analysis

The North America region holds the largest global automatic cell imaging system market share.

The North America automatic cell imaging system market is expected to grow at a high CAGR throughout the forecast period, owing to increasing initiatives by the government toward biomedical research. For instance, according to the American Association for the Advancement of Science, Congress created the Advanced Research Projects Agency for Health (ARPA-H), provided around $1 billion for startup investment, and has plans to provide $6.5 billion in funding. Furthermore, most of the key market players, such as Axion BioSystems, BD, BioTek Instruments, and Thermo Fisher Scientific, hold the majority of market share through various market strategies, ensuring the growth of the North America automatic cell imaging systems. For instance, in March 2022, Axion BioSystems, a leading life sciences tools company focused on advanced live-cell assay systems, acquired the Netherlands-based CytoSMART Technologies, an innovator in kinetic live-cell imaging analysis. Thus, the data above indicates that North America will hold most of the global automatic cell imaging systems market throughout the forecasted period (2022-2029).

Competitive Landscape

The automatic cell imaging system market is moderately competitive due to crucial local and global players involved in the research and innovation of new developments. Some of the key players include Axion BioSystems, Leica Microsystems, GE Healthcare Life Sciences, Olympus, BD, BioTek Instruments, PerkinElmer Inc., HORIBA Medical, Oxford Instruments, and Thermo Fisher Scientific. These key players hold the major share of the market through innovations, product launches, collaborations, acquisitions, and alliances. For instance, in May 2020, CytoSMART Technologies introduced a new live-cell imaging system. The CytoSMART Lux2 Duo Kit offers a straightforward, cost-effective solution to researchers carrying out immediate side-by-side comparisons between cell cultures.

ThermoFisher Scientific

Overview:

ThermoFisher is a U.S.-based company founded in 1956. It is the world leader in serving science with annual revenue of approx. $40 billion has industry-leading brands such as Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD.

Product Portfolio:

The product portfolio of ThermoFisher for Automatic Cell Imaging System has EVOS Cell Imaging Systems: EVOS imaging systems contain high-resolution cameras, bright and digitally controlled LED light sources, and automatic software to help capture stunning, publication-quality images in just a few clicks. These fully automated, multichannel fluorescence or brightfield microscopes feature advanced imaging tools to handle time-lapse movies, multiwell plate scanning, image stitching and tiling, and cell counting.

The global automatic cell imaging system market report would provide access to approximately 40 + market data tables, 45 + figures, and in the range of 200 (approximate) pages.